Malin Corp invests in Hatteras Venture Partners and Jaan Health

Irish global life sciences company Malin Corp has agreed to invest $15 million in North Carolina-based Hatteras Venture Partners, a venture firm that focuses on early-stage companies in life sciences. The investment could hike up to $20 million “depending on a number of factors.” Also, Malin has agreed to invest up to $1 million in New York-based healthcare mobile tech company Jaan Health. In addition to the investments, Malin CEO Adrian Howd will become the company’s chief investment officer while remaining on the company’s board of directors. And, Kelly Martin, who’s currently on Malin’s board of directors, will step into the Malin CEO position.

Cardax grabs $500K

Early-stage life sciences company Cardax has secured $500,000 in funding. The investors were not named.


German life sciences firm Pieris pulls in 6.6 mln euros

Munich-based life sciences company Pieris AG has raised 6.6 million euros in funding. The investors included Ally Bridge Group, OrbiMed, The Global Life Science Ventures, BioM Venture Capital, Gilde Europe Food & Agribusiness Fund and BayTech Venture Capital. Morrison & Foerster represented Ally Bridge Group in the transaction.


peHUB First Read

This Monday morning First Read brings you the latest on life sciences in Europe, Greyrock almost halfway to raising its third mezz fund and Vodafone to buy Spain’s Ono for over $10 billion.

Life Science “Big Exits” on the Rise

Who said there’s no liquidity in life science venture investment? Certainly not Silicon Valley Bank, which says now is a great time for making new biotech and medical device investments – and for exiting existing ones.

Life Sciences Venture Investing Represents 7th Best Quarter On Record, But All Is Not Blue Skies

Several weeks ago we reported that life sciences investing rose 37% from the first to the second quarters. Here are some additional details, courtesy of PricewaterhouseCoopers: First, with venture capitalists earmarking $2.1 billion for 206 companies, the quarter was the seventh best on record since the MoneyTree Report began collecting data in 1995. The MoneyTree […]

Covington Adds Four Partners To Life Sciences Practice

Covington & Burling LLP said Monday it added four partners to its life sciences team in London. The new attorneys – Paul Claydon, Natalie Diep, James Gubbins and James Halstead – will work on M&A, private equity and venture transactions. PRESS RELEASE Covington Adds Four Partners To Life Sciences Team LONDON, May 16, 2011 — […]

Slideshow: Life Sciences Deal Flow Falls, But Invested Dollars Creep Higher

Venture investors are stoked to the max on social networking and consumer Internet companies peddling daily deals or moneymaking online services. But as hot as frothy Web deals have become, life sciences transactions remain cold. GPs know it is hard to make money on complicated early-stage drug discovery, and public market IPO investors are less […]

2010 And 12 Exits Have Been Very, Very Good For Bessemer

Bessemer Venture Partners has had a good 2010. A string of 12 exits brought welcome liquidity to the firm, which has offices in India, the United States and Israel. The firm saw a more than 3X return overall from the dozen deals, according to Rob Chandra, a partner in its Menlo Park, Calif.-based office. “This […]

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget